MapLight Therapeutics (MPLT) Change in Cash (2024 - 2025)
MapLight Therapeutics (MPLT) posted Change in Cash of -$17.4 million for Q4 2025, down 259.63% sequentially from $10.9 million in Q4 2024, and down 259.63% YoY from $10.9 million in Q4 2024.
Powered by 
Analysis
MapLight Therapeutics (MPLT) Change in Cash (2024 - 2025) Analysis & Trends
MapLight Therapeutics has reported Change in Cash for 2 years, with the latest figure at -$17.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | -37.42 Mn |
| 10 | MapLight Therapeutics | 635.58 Mn | 635.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -17.42 Mn |
| Sep 30, 2025 | 30.68 Mn |
| Dec 31, 2024 | 10.91 Mn |